Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-22

Clinical Trial Update: Safety and Efficacy Study of IV Artesunate to Treat Malaria [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating intravenous artesunate for malaria safety and efficacy has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Artesunate (artesunate)

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Malaria | Phase 2 | Status: COMPLETED | Results posted: 2017-03-22